Six-month interim report May – October 2009/10

• Order bookings increased 20* percent.
• Net sales rose 10* percent to SEK 3,131 M (2,492).
• Operating profit increased to SEK 321 M (118).
• Profit after taxes rose to SEK 211 M (59).
• Earnings per share after dilution improved to SEK 2.32 (0.67).
• Postitive cash flow from operating activities, improved to SEK 150 M (neg. 95).
Cash flow after investments was positive SEK 104 M (neg. 180).
• Elekta’s financial outlook remains unchanged with an increase in net sales by more than 8 percent in local currency, and operating profit increase in SEK of more than 35 percent.

Elekta

Elekta is a leading international medical-technology company offering advanced and innovative clinical solutions and services for precision radiation treatment of cancer and minimally invasive treatment of brain disorder...

View more


  CONTACT  
  • Stina Thorman
  • Vice President Corporate Communications
  • +46 8 587 254 37
  •  

Related documents

 
 
 
 
Social Media Pitch:
Six-month interim report May – October 2009/10